93 related articles for article (PubMed ID: 332464)
21. Resistance of enteropathogenic strains of Escherichia coli to penicillins and cephalosporins.
Garber N; Frimerman H
Isr J Med Sci; 1973 Jul; 9(7):888-94. PubMed ID: 4126067
[No Abstract] [Full Text] [Related]
22. [Effect of benzylpenicillin and new polysynthetic penicillins on staphylococci and effect of a number of factors on antibacterial activity of these preparations].
Moroz AF; Vaĭntraub EA
Antibiotiki; 1968 Feb; 13(2):149-55. PubMed ID: 4875639
[No Abstract] [Full Text] [Related]
23. [Comparative studies on the behavior of 109 Escherichia coli strains against penicillin G and ampicillin].
Breitfellner G; Neuhold R
Chemotherapy; 1965-1966; 10(5):291-6. PubMed ID: 5331725
[No Abstract] [Full Text] [Related]
24. [Mechanism of the resistance of gram-negative bacteria to benzylpenicillin and ampicillin].
Makarova RA; Chaĭkovskaia SM
Antibiotiki; 1968 Jan; 13(1):30-7. PubMed ID: 4873975
[No Abstract] [Full Text] [Related]
25. FT-IR spectroscopy study of perturbations induced by antibiotic on bacteria (Escherichia coli).
Zeroual W; Manfait M; Choisy C
Pathol Biol (Paris); 1995 Apr; 43(4):300-5. PubMed ID: 7567119
[TBL] [Abstract][Full Text] [Related]
26. Terpene compounds as drugs. 8. Bacteriological and pharmacological properties of terpenyl penicillins.
Pala G; Casadio S; Coppi G; Crescenzi E; Mantegani A
Arzneimittelforschung; 1970 Jan; 20(1):62-8. PubMed ID: 4986283
[No Abstract] [Full Text] [Related]
27. [Aminocyclohexyl penicillin (Cyclacillin)].
Ueda Y; Matsumoto F; Nakamura N; Saito A; Noda K
Jpn J Antibiot; 1970 Feb; 23(1):48-52. PubMed ID: 4915210
[No Abstract] [Full Text] [Related]
28. [An extracellular penicillinase controlled by an R factor].
Romero E; Perduca M
G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):204-10. PubMed ID: 4605499
[No Abstract] [Full Text] [Related]
29. Comparative assessment of cylacillin and ampicillin by experimental therapy and by serum level determinations in rats and mice.
Freiesleben H; Sack K
Chemotherapy; 1976; 22(2):75-83. PubMed ID: 1253633
[TBL] [Abstract][Full Text] [Related]
30. Haemophilus influenzae infections. The impact of resistance on the use of aminopenicillins and other antimicrobials in outpatient therapy.
Marks MI
Clin Pediatr (Phila); 1984 Oct; 23(10):535-41. PubMed ID: 6331939
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between the structure and function of polysynthetic penicillins].
Naĭler Dzh
Antibiotiki; 1971 Oct; 16(10):877-82. PubMed ID: 5003055
[No Abstract] [Full Text] [Related]
32. Antimicrobial activity of cyclacillin against Escherichia coli in vivo and in vitro.
Friedman H; Warren GH
Experientia; 1971 Oct; 27(10):1241-3. PubMed ID: 4331424
[No Abstract] [Full Text] [Related]
33. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
Laxer RM; Mackay E; Marks MI
Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
[TBL] [Abstract][Full Text] [Related]
34. Absorption of amino penicillins from everted rat intestine.
Dixon C; Mizen LW
J Physiol; 1977 Aug; 269(3):549-59. PubMed ID: 894604
[TBL] [Abstract][Full Text] [Related]
35. Therapy of staphylococcal infections in monkeys. VII. Comparison of cyclacillin and nafcillin.
Carlisle HN; Saslaw S
Appl Microbiol; 1971 Nov; 22(5):865-9. PubMed ID: 5002313
[TBL] [Abstract][Full Text] [Related]
36. Promethazine renders Escherichia coli susceptible to penicillin G: real-time measurement of bacterial susceptibility by fluoro-luminometry.
Lehtinen J; Lilius EM
Int J Antimicrob Agents; 2007 Jul; 30(1):44-51. PubMed ID: 17475447
[TBL] [Abstract][Full Text] [Related]
37. Interactions of Escherichia coli and Proteus mirabilis with mouse mononuclear phagocytes.
Wells CL; Jechorek RP; Nelson RD
J Med Microbiol; 1990 Nov; 33(3):153-63. PubMed ID: 2250285
[TBL] [Abstract][Full Text] [Related]
38. Comparative evaluation of cyclacillin and ampicillin in urinary tract infections. A double-blind study.
Henri A; Klastersky J
Chemotherapy; 1974; 20(2):102-12. PubMed ID: 4367636
[No Abstract] [Full Text] [Related]
39. [New development on the field of antibiotic therapy].
Naumann P
Internist (Berl); 1975 Sep; 16(9):407-15. PubMed ID: 810448
[No Abstract] [Full Text] [Related]
40. Serum and urinary concentrations of cyclacillin in humans.
Hertz CG
Antimicrob Agents Chemother; 1973 Sep; 4(3):361-5. PubMed ID: 4357182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
